Epstein–Barr virus and gastric carcinoma in Western patients: comparison of pathological parameters and p53 expression in EBV‐positive and negative tumours
- 1 March 2000
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 36 (3) , 252-261
- https://doi.org/10.1046/j.1365-2559.2000.00843.x
Abstract
The presence of Epstein–Barr virus (EBV) was studied in 56 gastric carcinomas from Western patients by in-situ hybridization for EBV-encoded RNAs (EBER). EBV-positive and negative carcinomas were compared for various pathological parameters including p53 overexpression. EBERs transcripts were detected in seven cases overall: four cases of 52 conventional carcinomas (7.7%) and three cases of four gastric carcinomas with lymphoid stroma (75%). EBER positivity was diffuse in five cases and restricted to a localized area of the tumour in two cases of conventional carcinoma. A monoclonal EBV genomic pattern was demonstrated in the case tested by Southern blot analysis. By immunohistochemical analysis, neither EBV latent or lytic cycle proteins nor C3d/EBV receptor were expressed by neoplastic cells. EBER positivity was significantly correlated with prominent lymphoid reaction (P = 0.0002) which was associated with numerous PS100-positive dendritic cells and with HLA-DR expression by tumour cells (P = 0.03). p53 immunoreactivity in more than 30% of tumour cells was detected in 25 out 49 EBV-negative cases and was absent in EBV-positive cases except in one case with focal EBER-positivity. Focal staining for EBER is an unusual finding in the setting of gastric carcinoma and these results suggest that there might be two types of EBV-associated gastric carcinoma in which the viral infection will play a different role. The presence of a stromal lymphoid reaction which is strongly correlated with EBV positivity, is associated with antigen-presenting ability by HLA-DR-positive tumour cells or abundant dendritic cells. The function of p53 appears preserved in all EBV-associated carcinomas except in one case with focal EBER expression whereas the immunohistochemical pattern of p53 is suggestive of a mutational phenomenon in 51% of EBV-negative cases.Keywords
This publication has 38 references indexed in Scilit:
- Epstein–Barr virus‐associated primary gastrointestinal lymphoma in non‐immunocompromised patients in KoreaHistopathology, 1997
- Infrequent Overexpression of p53 Protein in Epstein‐Barr Virus‐associated Gastric CarcinomasJapanese Journal of Cancer Research, 1997
- Detection of Epstein-Barr Virus DNA in Gastric Carcinoma with Lymphoid StromaViral Immunology, 1997
- Association of the Epstein-Barr Virus with Hematolymphoid NeoplasiaAdvances in Anatomic Pathology, 1996
- Epstein‐Barr virus in B‐cell non‐Hodgkin's lymphomas: Unexpected infection patterns and different infection incidence in low‐ and high‐grade typesThe Journal of Pathology, 1995
- Epstein‐Barr virus association with early cancers found together with gastric medullary carcinomas demonstrating lymphoid infiltrationThe Journal of Pathology, 1995
- Epstein-Barr virus in gastric carcinoma and adjacent normal gastric and duodenal mucosa.Journal of Clinical Pathology, 1994
- Epstein‐barr virus and gastric cancer: Data and unanswered questionsInternational Journal of Cancer, 1993
- Epstein-Barr Virus and Carcinomas Expression of the Viral Genome in an Undifferentiated Gastric CarcinomaDiagnostic Molecular Pathology, 1992
- Immunoglobulin A-Induced Shift of Epstein-Barr Virus Tissue TropismScience, 1992